Opioid overdose deaths are ~80,000 a year in the US. Many overdose patients are found alone and unconscious, unable to use existing antidote sprays and injectors solutions. Antidote administration is delayed until EMS arrives and such delay leads to a multitude of problems, including hypoxemia, brain damage, intensive care, and high healthcare costs.
Revolutionizing opioid overdose detection and treatment
Discrete. Comprehensive. Automatic.
A2D2 reverses opioid overdoses automatically.
3D rendering - product in development
Rescue Biomedical’s Automatic Antidote Delivery Device (A2D2) is a innovative wearable device that automatically detects and treats opioid overdose, establishing a closed-loop drug-delivery system.
Upon detection of an overdose, the A2D2 autonomously administers naloxone through a needle-free injector to restore normal breathing while simultaneously alerting emergency contacts to ensure immediate medical intervention.
a2d2 Allows for timely administration of naloxone, increasing chances of survival and reduced risk of long-term effects
Reduction in intensive treatment
Immediate administration of naloxone minimizes the chances of brain hypoxia, reducing the risk of lasting neurological damage.
Decrease in hospitalization days
Early intervention minimizes the need for complex medical procedures by reducing damages caused by an overdose, allowing patients to recover faster.
Saving in treatment costs
Economic burden on patients and the healthcare ecosystem will decrease significantly as lengthy, costly hospital stays are prevented.
Continuous Monitoring
Support for Friends & Families